|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.695 EUR | +0.98% |
|
+0.89% | -2.34% |
| 06-18 | Nordea raises target price for Lundbeck to DKK60 (57), reiterates buy rating | FW |
| 06-14 | H. Lundbeck A/S Presents Preliminary Phase II Part A Data for Asedebart in Cushing's Disease | CI |
Company Valuation: Lundbeck
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 25,433 | 31,719 | 39,416 | 41,398 | 40,851 | - | - |
| Change | - | 24.72% | 24.27% | 5.03% | -1.32% | - | - |
| Enterprise Value (EV) 1 | 27,464 | 31,008 | 51,598 | 49,619 | 44,946 | 40,744 | 36,711 |
| Change | - | 12.91% | 66.4% | -3.84% | -9.42% | -9.35% | -9.9% |
| P/E | 13.5x | 14.2x | 13x | 13.4x | 9.34x | 9.11x | 9.74x |
| PBR | 1.24x | 1.47x | 1.64x | 1.72x | 1.45x | 1.3x | 1.19x |
| PEG | - | 0.7x | 0.3x | 8.5x | 0.2x | 3.54x | -1.51x |
| Capitalization / Revenue | 1.39x | 1.59x | 1.79x | 1.68x | 1.59x | 1.58x | 1.63x |
| EV / Revenue | 1.51x | 1.56x | 2.34x | 2.01x | 1.75x | 1.58x | 1.47x |
| EV / EBITDA | 5.89x | 5.49x | 8.13x | 6.3x | 5.57x | 5.02x | 4.78x |
| EV / EBIT | 9.63x | 9.71x | 15.8x | 9.41x | 7.47x | 6.62x | 6.36x |
| EV / FCF | 10.2x | 8.66x | 18.7x | 10.2x | 8x | 6.53x | 6.57x |
| FCF Yield | 9.83% | 11.5% | 5.35% | 9.8% | 12.5% | 15.3% | 15.2% |
| Dividend per Share 2 | 0.58 | 0.7 | 0.95 | 1.15 | 1.475 | 1.533 | 1.49 |
| Rate of return | 2.23% | 2.14% | 2.3% | 2.66% | 3.48% | 3.61% | 3.51% |
| EPS 2 | 1.93 | 2.31 | 3.17 | 3.22 | 4.54 | 4.657 | 4.357 |
| Distribution rate | 30.1% | 30.3% | 30% | 35.7% | 32.5% | 32.9% | 34.2% |
| Net sales 1 | 18,246 | 19,912 | 22,004 | 24,630 | 25,744 | 25,845 | 25,016 |
| EBITDA 1 | 4,663 | 5,652 | 6,347 | 7,881 | 8,064 | 8,118 | 7,686 |
| EBIT 1 | 2,852 | 3,195 | 3,270 | 5,275 | 6,020 | 6,153 | 5,773 |
| Net income 1 | 1,916 | 2,290 | 3,143 | 3,192 | 4,744 | 4,856 | 4,692 |
| Net Debt 1 | 2,031 | -711 | 12,182 | 8,221 | 4,095 | -107.4 | -4,140 |
| Reference price 2 | 26.05 | 32.76 | 41.32 | 43.16 | 42.42 | 42.42 | 42.42 |
| Nbr of stocks (in thousands) | 992,840 | 992,840 | 992,011 | 991,227 | 991,227 | - | - |
| Announcement Date | 2/7/23 | 2/7/24 | 2/5/25 | 2/4/26 | - | - | - |
1DKK in Million2DKK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 17.68x | 0.21x | 12.28x | 0.44% | 87.52B | ||
| 30.42x | 0.24x | 15.21x | 0.87% | 55.32B | ||
| 43.89x | 3.1x | 28.77x | 1.41% | 22.16B | ||
| 11.02x | 0.2x | 4.71x | 2.73% | 7.91B | ||
| 12.79x | 0.98x | 7.9x | 2.64% | 7.41B | ||
| 5.63x | 0.09x | 2.63x | 5.33% | 6.43B | ||
| 24.39x | 1.17x | 14.47x | 2.96% | 5.28B | ||
| 10.21x | 0.11x | 4.18x | 4.38% | 3.5B | ||
| 13.42x | - | - | 2.41% | 3.36B | ||
| Average | 18.83x | 0.76x | 11.27x | 2.57% | 22.1B | |
| Weighted average by Cap. | 23.28x | 0.60x | 14.10x | 1.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- HLUN B Stock
- LUNB Stock
- Valuation Lundbeck
Select your edition
All financial news and data tailored to specific country editions
















